| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 157, Issue 7 2989-2997, Copyright © 1996 by American Association of Immunologists
ARTICLES |
M Rheinnecker, C Hardt, LL Ilag, P Kufer, R Gruber, A Hoess, A Lupas, C Rottenberger, A Pluckthun and P Pack
MorphoSys GmbH, Munich, Germany.
We report in this work a human-derived self-assembling polypeptide based on the tetramerization domain of the human transcription factor p53, which can be fused to single-chain Fv Ab (scFv) fragments via a long and flexible hinge sequence of human origin, allowing exploitation of the functional affinity increase of binding to a ligand or cell surface with multimeric binding sites. We have demonstrated the use of this polypeptide by applying it to the construction of a tetrameric scFv against the tumor-associated carbohydrate Ag Lewis Y (Fuc alpha 1-- >2Gal beta 1-->4[Fuc alpha 1-->3] GlcNAc beta 1-->3R). For comparison purposes, the corresponding scFv and dimeric mini-antibody, comprising the scFv fused via a flexible murine hinge to an artificial dimerization domain, were also created. The recombinant mini-antibody proteins were expressed in functional form in Escherichia coli and showed the expected m.w. of a dimer and tetramer, respectively. Analysis of Lewis Y-binding behavior by surface plasmon resonance revealed specific but very weak binding of the scFv fragment. In contrast, both dimeric and tetrameric scFv fusion proteins exhibited an enormous gain in functional affinity that was greatest in the case of the tetrameric mini-antibody.
This article has been cited by other articles:
|
|
 |
|
  S. Kubetzko, E. Balic, R. Waibel, U. Zangemeister-Wittke, and A. Pluckthun PEGylation and Multimerization of the Anti-p185HER-2 Single Chain Fv Fragment 4D5: EFFECTS ON TUMOR TARGETING J. Biol. Chem., November 17, 2006; 281(46): 35186 - 35201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Loset, K. H. Roux, P. Zhu, T. E. Michaelsen, and I. Sandlie Differential Segmental Flexibility and Reach Dictate the Antigen Binding Mode of Chimeric IgD and IgM: Implications for the Function of the B Cell Receptor J. Immunol., March 1, 2004; 172(5): 2925 - 2934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Goel, D. Colcher, J. Baranowska-Kortylewicz, S. Augustine, B. J. M. Booth, G. Pavlinkova, and S. K. Batra Genetically Engineered Tetravalent Single-Chain Fv of the Pancarcinoma Monoclonal Antibody CC49: Improved Biodistribution and Potential for Therapeutic Application Cancer Res., December 1, 2000; 60(24): 6964 - 6971. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Scott, D. Geleick, M. Rubira, K. Clarke, E. C. Nice, F. E. Smyth, E. Stockert, E. C. Richards, F. J. Carr, W. J. Harris, et al. Construction, Production, and Characterization of Humanized Anti-Lewis Y Monoclonal Antibody 3S193 for Targeted Immunotherapy of Solid Tumors Cancer Res., June 1, 2000; 60(12): 3254 - 3261. [Abstract] [Full Text]
|
|
|
|
 |
|
 Z. Zuo, X. Jimenez, L. Witte, and Z. Zhu An efficient route to the production of an IgG-like bispecific antibody Protein Eng. Des. Sel., May 1, 2000; 13(5): 361 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Graversen, R. H. Lorentsen, C. Jacobsen, S. K. Moestrup, B. W. Sigurskjold, H. C. Thogersen, and M. Etzerodt The Plasminogen Binding Site of the C-Type Lectin Tetranectin Is Located in the Carbohydrate Recognition Domain, and Binding Is Sensitive to Both Calcium and Lysine J. Biol. Chem., October 30, 1998; 273(44): 29241 - 29246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Willuda, S. Kubetzko, R. Waibel, P. A. Schubiger, U. Zangemeister-Wittke, and A. Pluckthun Tumor Targeting of Mono-, Di-, and Tetravalent Anti-p185HER-2 Miniantibodies Multimerized by Self-associating Peptides J. Biol. Chem., April 20, 2001; 276(17): 14385 - 14392. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
